BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib
BRCA1 甲基化的三阴性乳腺癌,曾接受过新辅助化疗,形成 RAD51 病灶,对奥拉帕尼反应不佳
期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2023.1125021
Carolina Velazquez, Esin Orhan, Imene Tabet, Lise Fenou, Béatrice Orsetti, José Adélaïde, Arnaud Guille, Simon Thézénas, Evelyne Crapez, Pierre-Emmanuel Colombo, Max Chaffanet, Daniel Birnbaum, Claude Sardet, William Jacot, Charles Theillet